TP53 and acute myeloid leukemia: Here, we report that, in contrast to the mixed AML and T cell malignancy that developed in NrasG12D/+p53–/– (NP–/–) mice, NrasG12D/+p53R172H/+ (NPmut) mice rapidly developed inflammation-associated AML.